Publication | Open Access
Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with <scp>anti‐PD</scp>‐1 antibody
55
Citations
36
References
2020
Year
This study demonstrated that serum sPD-L1 level was an independent predictive and prognostic biomarker for NSCLC patients receiving anti-PD-1 antibody.
| Year | Citations | |
|---|---|---|
Page 1
Page 1